Newbridge Financial Services Group’s Greenwich LifeSciences GLSI Stock Holding History

Newbridge Financial Services Group’s Portfolio GLSI Stock Details GLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$49.3K	Hold	2,100	–	–	0.01%	493
2026 Q1	$50.4K	Hold	2,100	–	–	0.01%	421
2025 Q4	$44.1K	Hold	2,100	–	–	0.01%	457
2025 Q3	$20.9K	Hold	2,100	–	–	﹤0.01%	737
2025 Q2	$19K	Buy	2,100 +800	+62%	+$7.61K	﹤0.01%	739
2025 Q1	$12.4K	Hold	1,300	–	–	﹤0.01%	641
2024 Q4	$14.6K	Buy	+1,300	New	+$17.4K	﹤0.01%	670
2024 Q3	–	Sell	-1,900	Closed	-$32.8K	–	820
2024 Q2	$32.8K	Buy	1,900 +400	+27%	+$5.84K	0.01%	476
2024 Q1	$29.9K	Hold	1,500	–	–	0.01%	517
2023 Q4	$15.8K	Hold	1,500	–	–	0.01%	638
2023 Q3	$13.3K	Hold	1,500	–	–	0.01%	745
2023 Q2	$14.5K	Buy	1,500 +600	+67%	+$6.71K	0.01%	798
2023 Q1	$12.4K	Buy	900 +400	+80%	+$6.35K	0.01%	870
2022 Q4	$7.6K	Hold	500	–	–	﹤0.01%	977
2022 Q3	$5K	Hold	500	–	–	﹤0.01%	1041
2022 Q2	$4K	Hold	500	–	–	﹤0.01%	1051
2022 Q1	$10K	Hold	500	–	–	﹤0.01%	937
2021 Q4	$12K	Hold	500	–	–	0.01%	875
2021 Q3	$20K	Buy	+500	New	+$20.9K	0.01%	662

Other funds holding GLSI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Newbridge Financial Services Group's GLSI Position: Q2 2026 in Review

Newbridge Financial Services Group held its Greenwich LifeSciences (GLSI) position steady in Q2 2026 at 2,100 shares worth $49.3K. The position accounts for 0.01% of the portfolio, ranked #493.

Newbridge Financial Services Group first reported a position in GLSI in Q3 2021 and has held it in 19 quarters since. The position peaked at $50.4K in Q1 2026. 58 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

Newbridge Financial Services Group held 2,100 shares of Greenwich LifeSciences worth $49.3K as of Q2 2026.
Newbridge Financial Services Group left its Greenwich LifeSciences share count unchanged in Q2 2026.
Greenwich LifeSciences made up 0.01% of Newbridge Financial Services Group's portfolio in Q2 2026, its #493 holding.
Newbridge Financial Services Group first reported a position in Greenwich LifeSciences in Q3 2021 and has held it in 19 quarters since.
Newbridge Financial Services Group's Greenwich LifeSciences position peaked at $50.4K in Q1 2026.
58 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.